Regimens of Ivermectin for Scabies Elimination: a cluster randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy.

Murdoch Children's Research Institute0 个研究点目标入组 8,609 人开始时间: 2018年6月28日最近更新: 2021年11月15日

适应症

试验速览

暂无简介。

•All community members of selected villages who have provided consent are able to be included in this study. Provision of consent at baseline is for skin examination and treatment (as per allocated group), unless exclusion criteria for treatment are met in which case only skin examination will be conducted.
•Consent will be obtained at 12 months and at 24 months for skin examination only and all individuals who provide consent at these times will be included in the follow up assessment.

•If a potential participant meets any of the following exclusion criteria, they will be able to be included in the study (i.e. be enrolled and undergo skin examination) but will not receive treatment:
•-Allergy to any of the components of the allocated drug regimen,
•-Currently on, or has taken ivermectin in the previous 7 days,
•-Has had topical 5% permethrin applied within previous 7 days,
•-Refusal to take treatment,
•-Considered by study nurses to be too ill for treatment

发起方